🇺🇸 FDA
Patent

US 11787840

Compositions and methods for treating and preventing autoimmune induced cardiac long QT syndrome

granted A61KA61K38/00A61K39/00

Quick answer

US patent 11787840 (Compositions and methods for treating and preventing autoimmune induced cardiac long QT syndrome) held by United States Government as represented by the Department of Veterans Affairs expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United States Government as represented by the Department of Veterans Affairs
Grant date
Tue Oct 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K38/00, A61K39/00, A61P, A61P37/02